Sherri Jackson
Internal Medicine · Richmond, VANPI 1235346495
Payments from drug & device makers
Across 233 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$528
- Novo Nordisk$474
- AbbVie$464
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$241
- GSK$180
- Amgen$176
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,482100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 33 | $528 |
| Novo Nordisk | 38 | $474 |
| AbbVie(2 entities) | 28 | $464 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $241 |
| GSK | 7 | $180 |
| Amgen | 13 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $176 |
| Boehringer Ingelheim | 7 | $114 |
| Pfizer | 8 | $113 |
| Esperion Therapeutics, Inc. | 6 | $103 |
| Teva Pharmaceuticals USA, Inc. | 7 | $97 |
| Sanofi-aventis U.S. LLC | 7 | $95 |
| Abbott | 5 | $94 |
| Upsher-smith Laboratories LLC | 4 | $79 |
| AstraZeneca | 5 | $69 |
| Genentech USA, Inc. | 4 | $59 |
| Novartis | 3 | $59 |
| Biohaven Pharmaceuticals, Inc. | 4 | $59 |
| Dexcom, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $41 |
| Merck | 3 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Johnson & Johnson | 2 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$3,482 in reported general payments places this provider in the 85th percentile of 2,724 internal medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 76 | $585 |
| Olmesartan Medoxomil | 20 | $527 |
| Pravastatin Sodium | 36 | $478 |
| Valsartan | 12 | $439 |
| Losartan Potassium | 38 | $411 |
| Levothyroxine Sodium | 42 | $409 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 13 | $264 |
| Amlodipine Besylate | 45 | $220 |
| Escitalopram Oxalate | 11 | $208 |
| Rosuvastatin Calcium | 19 | $175 |
| Atenolol | 13 | $125 |
| Metoprolol Succinate | 14 | $115 |
| Hydrochlorothiazide | 19 | $108 |
| Metformin Hcl ErMetformin Hcl | 18 | $98 |
| Simvastatin | 28 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $40942 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 internal medicine providers in Virginia.
Other internal medicine in Richmond
- Leroy VaughanRichmond$20.8M
- Andrew PoklepovicRichmond$4.6M
- Richard JacksonRichmond$2.5M
- Lawrence SchwartzRichmond$2.4M
- John HoekstraRichmond$344K
- Franklin ZieveRichmond$337K
- Wally SmithRichmond$333K
- Thokozeni LipatoRichmond$247K
- John BarrettRichmond$217K
- Alan DowRichmond$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.